Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Botulinum toxin type A for prevention of radiation-induced sialadenitis in head and neck cancer
2009-017378-19Phase 2Terminated
- Sponsor
- Dr. Antonio Mari Roig
- Start
- Jun 2011
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 2, open-label trial of botulinum toxin type A in sialadenitis and xerostomia (2 arms), sponsored by Dr. Antonio Mari Roig. Primary endpoint: Salivary gland functional variation by scintigraphy. Started Jun 2011; status: terminated.
02
Drugs
botulinum toxin type A
03
Conditions
sialadenitisxerostomia
Beyond the preview
Go deeper on 2009-017378-19.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2009-017378-19.